📧 Stock #1 — An e-commerce marketing platform with 110% NRR, $1B+ in cash, $200M in free cash flow in 2025, and 32% revenue growth — all founder-led, all built on a proprietary data moat that compounds with every campaign. The stock is sitting on a multi-year low. The business is not.

🏥 Stock #2 — The platform that 85% of U.S. physicians use daily. 60% adjusted EBITDA margins. 90%+ gross margins. A $500M buyback just authorised. Down 17% in a single session after guidance the market misread. The underlying engagement is at all-time highs.

📱 Stock #3 — A company that grew revenue +70% year-over-year in 2025 to $5.5B, printed an 84% adjusted EBITDA margin, generated $3.95B in free cash flow, and is guiding continued growth in 2026. The stock dropped after earnings. The numbers did not.